A Trial of SHR-1210 in Combination With Apatinib in Patients With Unresectable HCC
Clinical trial NCT03793725 · UNKNOWN
Trial details
- NCT number
- NCT03793725
- Sponsor
- Yanqiao Zhang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-30
- Primary completion
- 2020-01-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.